125 related articles for article (PubMed ID: 15254427)
1. p53-Dependent activation of a molecular beacon in tumor cells following exposure to doxorubicin chemotherapy.
Shah R; El-Deiry WS
Cancer Biol Ther; 2004 Sep; 3(9):871-5. PubMed ID: 15254427
[TBL] [Abstract][Full Text] [Related]
2. Involvement of sphingosine kinase 2 in p53-independent induction of p21 by the chemotherapeutic drug doxorubicin.
Sankala HM; Hait NC; Paugh SW; Shida D; Lépine S; Elmore LW; Dent P; Milstien S; Spiegel S
Cancer Res; 2007 Nov; 67(21):10466-74. PubMed ID: 17974990
[TBL] [Abstract][Full Text] [Related]
3. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
[TBL] [Abstract][Full Text] [Related]
4. p21 modulates threshold of apoptosis induced by DNA-damage and growth factor withdrawal in prostate cancer cells.
Martinez LA; Yang J; Vazquez ES; Rodriguez-Vargas Mdel C; Olive M; Hsieh JT; Logothetis CJ; Navone NM
Carcinogenesis; 2002 Aug; 23(8):1289-96. PubMed ID: 12151346
[TBL] [Abstract][Full Text] [Related]
5. Chk1 and Wee1 control genotoxic-stress induced G2-M arrest in melanoma cells.
Vera J; Raatz Y; Wolkenhauer O; Kottek T; Bhattacharya A; Simon JC; Kunz M
Cell Signal; 2015 May; 27(5):951-60. PubMed ID: 25683911
[TBL] [Abstract][Full Text] [Related]
6. WTp53 induction does not override MTp53 chemoresistance and radioresistance due to gain-of-function in lung cancer cells.
Cuddihy AR; Jalali F; Coackley C; Bristow RG
Mol Cancer Ther; 2008 Apr; 7(4):980-92. PubMed ID: 18413811
[TBL] [Abstract][Full Text] [Related]
7. c-ABL tyrosine kinase modulates p53-dependent p21 induction and ensuing cell fate decision in response to DNA damage.
Udden SM; Morita-Fujimura Y; Satake M; Ikawa S
Cell Signal; 2014 Feb; 26(2):444-52. PubMed ID: 24177958
[TBL] [Abstract][Full Text] [Related]
8. HCT116 cells deficient in p21(Waf1) are hypersensitive to tyrosine kinase inhibitors and adriamycin through a mechanism unrelated to p21 and dependent on p53.
Ferrandiz N; Martin-Perez J; Blanco R; Donertas D; Weber A; Eilers M; Dotto P; Delgado MD; Leon J
DNA Repair (Amst); 2009 Mar; 8(3):390-9. PubMed ID: 19150257
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175.
Hayward RL; Schornagel QC; Tente R; Macpherson JS; Aird RE; Guichard S; Habtemariam A; Sadler P; Jodrell DI
Cancer Chemother Pharmacol; 2005 Jun; 55(6):577-83. PubMed ID: 15726367
[TBL] [Abstract][Full Text] [Related]
10. Induction of the WAF1/CIP1 protein and apoptosis in human T-cell leukemia virus type I-transformed lymphocytes after treatment with adriamycin by using a p53-independent pathway.
Gartenhaus RB; Wang P; Hoffmann P
Proc Natl Acad Sci U S A; 1996 Jan; 93(1):265-8. PubMed ID: 8552618
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms underlying the pro-survival pathway of p53 in suppressing mitotic death induced by adriamycin.
Lin YC; Wang FF
Cell Signal; 2008 Jan; 20(1):258-67. PubMed ID: 18006273
[TBL] [Abstract][Full Text] [Related]
12. Role of the p53/p21 system in the response of human colon carcinoma cells to Doxorubicin.
Ravizza R; Gariboldi MB; Passarelli L; Monti E
BMC Cancer; 2004 Dec; 4():92. PubMed ID: 15601469
[TBL] [Abstract][Full Text] [Related]
13. Induction of p21(Waf1/Cip1) by garcinol via downregulation of p38-MAPK signaling in p53-independent H1299 lung cancer.
Yu SY; Liao CH; Chien MH; Tsai TY; Lin JK; Weng MS
J Agric Food Chem; 2014 Mar; 62(9):2085-95. PubMed ID: 24533688
[TBL] [Abstract][Full Text] [Related]
14. p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents.
Mahyar-Roemer M; Roemer K
Oncogene; 2001 Jun; 20(26):3387-98. PubMed ID: 11423989
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylated Hsp27 activates ATM-dependent p53 signaling and mediates the resistance of MCF-7 cells to doxorubicin-induced apoptosis.
Xu Y; Diao Y; Qi S; Pan X; Wang Q; Xin Y; Cao X; Ruan J; Zhao Z; Luo L; Liu C; Yin Z
Cell Signal; 2013 May; 25(5):1176-85. PubMed ID: 23357534
[TBL] [Abstract][Full Text] [Related]
16. Hypersensitivity to chromium-induced DNA damage correlates with constitutive deregulation of upstream p53 kinases in p21-/- HCT116 colon cancer cells.
Hill R; Leidal AM; Madureira PA; Gillis LD; Cochrane HK; Waisman DM; Chiu A; Lee PW
DNA Repair (Amst); 2008 Feb; 7(2):239-52. PubMed ID: 18024214
[TBL] [Abstract][Full Text] [Related]
17. Monitoring daunorubicin-induced alterations in protein expression in pancreas carcinoma cells by two-dimensional gel electrophoresis.
Möller A; Malerczyk C; Völker U; Stöppler H; Maser E
Proteomics; 2002 Jun; 2(6):697-705. PubMed ID: 12112851
[TBL] [Abstract][Full Text] [Related]
18. DNA-dependent protein kinase inhibitor (OK-1035) suppresses p21 expression in HCT116 cells containing wild-type p53 induced by adriamycin.
Take Y; Kumano M; Teraoka H; Nishimura S; Okuyama A
Biochem Biophys Res Commun; 1996 Apr; 221(2):207-12. PubMed ID: 8619835
[TBL] [Abstract][Full Text] [Related]
19. TNF-alpha promotes Doxorubicin-induced cell apoptosis and anti-cancer effect through downregulation of p21 in p53-deficient tumor cells.
Cao W; Chi WH; Wang J; Tang JJ; Lu YJ
Biochem Biophys Res Commun; 2005 May; 330(4):1034-40. PubMed ID: 15823547
[TBL] [Abstract][Full Text] [Related]
20. The mutant p53-conformation modifying drug, CP-31398, can induce apoptosis of human cancer cells and can stabilize wild-type p53 protein.
Takimoto R; Wang W; Dicker DT; Rastinejad F; Lyssikatos J; el-Deiry WS
Cancer Biol Ther; 2002; 1(1):47-55. PubMed ID: 12174820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]